Free Access
Vet. Res.
Volume 35, Number 5, September-October 2004
Page(s) 573 - 584
How to cite this article Vet. Res. (2004) 573-584
References of Vet. Res. 35 573-584
  1. Archer S., Measurement of nitric oxide in biological models, FASEB J. 7 (1993) 349-360 [PubMed].
  2. Baeza E., Poitou I., Delers F., Boulard C., Influence of anti-inflammatory treatments on experimental infection of rats with Fasciola hepatica: changes in serum levels of inflammatory markers during the early stages of fasciolosis, Res. Vet. Sci. 57 (1994) 172-179 [PubMed].
  3. Baeza E., Poitou I., Boulard C., Influence of pro-inflammatory treatments on experimental infection of rats with Fasciola hepatica: changes in serum levels of inflammatory markers during the early stages of fasciolosis, Res. Vet. Sci. 57 (1994) 180-187 [PubMed].
  4. Cervi L., Masih D.T., Inhibition of spleen cell proliferative response to mitogens by excretory-secretory antigens of Fasciola hepatica, Int. J. Parasitol. 27 (1997) 573-579 [PubMed].
  5. Cervi L., Rossi G., Masih D.T., Potential role for excretory-secretory forms of glutathione-S-transferase (GST) in Fasciola hepatica, Parasitology 119 (1999) 627-633 [CrossRef].
  6. Dargie J.D., The impact on production and mechanisms of pathogenesis of trematode infections in cattle and sheep, Int. J. Parasitol. 17 (1987) 453-463 [PubMed].
  7. Davies C., Goose J., Killing of newly excysted juveniles of Fasciola hepatica in sensitized rats, Parasite Immunol. 3 (1981) 81-96 [PubMed].
  8. Doy T.G., Hughes D.L., In vitro cell adherence to newly excysted Fasciola hepatica: failure to affect their subsequent development in rats, Res. Vet. Sci. 32 (1982) 118-120 [PubMed].
  9. Doy T.G., Hughes D.L., Evidence for two distinct mechanisms of resistance in the rat to reinfection with Fasciola hepatica, Int. J. Parasitol. 12 (1982) 357-361 [PubMed].
  10. El-Ghaysh A., Turner R.J., Brophy P.M., Barrett J., Effect of Fasciola gigantica somatic extracts and excretory/secretory products on superoxide production by activated neutrophils, Vet. Parasitol. 84 (1999) 91-100 [PubMed].
  11. Gazzinelli R.T., Oswald I.P., Hieny S., James S.L., Sher A., The microbicidal activity of interferon-gamma-treated macrophages against Trypanosoma cruzi involves an L-arginine-dependent, nitrogen oxide-mediated mechanism inhibitable by interleukin-10 and transforming growth factor-beta, Eur. J. Immunol. 22 (1992) 2501-2506 [PubMed].
  12. Goose J., Possible role of excretory/secretory products in evasion of host defences by Fasciola hepatica, Nature 275 (1978) 216-217 [PubMed].
  13. Haroun E.T., Hillyer G.V., Resistance to fascioliasis - a review, Vet. Parasitol. 20 (1986) 63-93 [PubMed].
  14. Haroun E.M., Hammond J.A., Sewell M.M., Passive transfer of humoral resistance to Fasciola hepatica in rats and rabbits, Res. Vet. Sci. 30 (1981) 309-311 [PubMed].
  15. Jacobs P., Radzioch D., Stevenson M.M., Nitric oxide expression in the spleen, but not in the liver, correlates with resistance to blood-stage malaria in mice, J. Immunol. 155 (1995) 5306-5313 [PubMed].
  16. James S.L., Glaven J., Macrophage cytotoxicity against schistosomula of Schistosoma mansoni involves arginine-dependent production of reactive nitrogen intermediates, J. Immunol. 143 (1989) 4208-4212 [PubMed].
  17. Jefferies J.R., Barrett J., Turner R.J., Immunomodulation of sheep and human lymphocytes by Fasciola hepatica excretory-secretory products, Int. J. Parasitol. 26 (1996) 1119-1121 [PubMed].
  18. Jefferies J.R., Turner R.J., Barrett J., Effect of Fasciola hepatica excretory-secretory products on the metabolic burst of sheep and human neutrophils, Int. J. Parasitol. 27 (1997) 1025-1029 [PubMed].
  19. Meek A.H., Morris R.S., The effect of prior infection with Fasciola hepatica on the resistance of sheep to the same parasite, Aust. Vet. J. 55 (1979) 61-64 [PubMed].
  20. Oldham G., Immune responses in rats and cattle to primary infections with Fasciola hepatica, Res. Vet. Sci. 39 (1985) 357-363 [PubMed].
  21. Oliveira S.H.P., Fonseca S.G., Romao P.R.T., Figueiredo F., Ferreira S.H., Cunha F.Q., Microbicidal activity of eosinophils is associated with activation of the arginine-NO pathway, Parasite Immunol. 20 (1998) 405-412 [CrossRef].
  22. Overend D.J., Bowen F.L., Resistance of Fasciola hepatica to triclabendazole, Aust. Vet. J. 72 (1995) 275-276 [PubMed].
  23. Pick E., Mizel D., Rapid microassays for the measurement of superoxide and hydrogen peroxide production by macrophages in culture using an automatic enzyme immunoassay reader, J. Immunol. Methods 46 (1981) 211-226 [CrossRef].
  24. Piedrafita D., Spithill T.W., Dalton J.P., Brindley P.J., Sandeman M.R., Wood P.R., Parsons J.C., Juvenile Fasciola hepatica are resistant to killing in vitro by free radicals compared with larvae of Schistosoma mansoni, Parasite Immunol. 22 (2000) 287-295 [CrossRef].
  25. Piedrafita D., Parsons J.C., Sandeman R.M., Wood P.R., Estuningsih S.E., Partoutomo S., Spithill T.W., Antibody-dependent cell-mediated cytotoxicity to newly excysted juvenile Fasciola hepatica in vitro is mediated by reactive nitrogen intermediates, Parasite Immunol. 23 (2001) 473-482 [CrossRef].
  26. Smith M.A., Clegg J.A., Improved culture of F. hepatica in vitro, Z. Parasitenkd. 66 (1981) 9 [PubMed].
  27. Spithill T.W., Dalton J.P., Progress in development of liver fluke vaccines, Parasitol. Today 14 (1998) 224-228 [CrossRef].
  28. Tliba O., Sibille P., Boulard C., Chauvin A., Local hepatic immune response in rats during primary infection with Fasciola hepatica, Parasite 7 (2000) 9-18 [PubMed].
  29. Tliba O., Sibille P., Boulard C., Chauvin A., Early hepatic cytokine mRNA expression in experimental rat fasciolosis, Vet. Parasitol. 103 (2002) 237-249 [PubMed].
  30. Tliba O., Moire N., Vern Y.L., Boulard C., Chauvin A., Sibille P., Early hepatic immune response in rats infected with Fasciola hepatica, Vet. Res. 33 (2002) 261-270 [EDP Sciences].
  31. Torgerson P., Claxton J., Fasciolosis: epidemiology and control, in: Dalton J.P. (Ed.), Fasciolosis, CAB International, Wallingford, 1999, pp. 113-150.
  32. Van Milligen F.J., Cornelissen J.B.W.J., Bokhout B.A., Location of induction and expression of protective immunity against Fasciola hepatica at the gut level: a study using an ex vivo infection model with ligated gut segments, J. Parasitol. 84 (1998) 771-777 [PubMed].
  33. Van Milligen F.J., Cornelissen J.B.W.J., Bokhout B.A., Protection against Fasciola hepatica in the intestine is highly correlated with eosinophil and immunoglobulin G1 responses against newly excysted juveniles, Parasite Immunol. 21 (1999) 243-251 [CrossRef].